Hemodynamic Deterioration During Extracorporeal Membrane Oxygenation Weaning in a Patient With a Total Artificial Heart
- 1 January 2015
- journal article
- case report
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 43 (1) , e19-e22
Abstract
The Total Artificial Heart (Syncardia, Tucson, AZ) is approved for use as a bridge-to-transplant or destination therapy in patients who have irreversible end-stage biventricular heart failure. We present a unique case, in which the inferior vena cava compression by a total artificial heart was initially masked for days by the concurrent placement of an extracorporeal membrane oxygenation cannula. This is the case of a 33-year-old man admitted to our institution with recurrent episodes of ventricular tachycardia requiring emergent total artificial heart and venovenous extracorporeal membrane oxygenation placement. This interesting scenario highlights the importance for critical care physicians to have an understanding of exact anatomical localization of a total artificial heart, extracorporeal membrane oxygenation, and their potential interactions. In total artificial heart patients with hemodynamic compromise or reduced device filling, consideration should always be given to venous inflow compression, particularly in those with smaller body surface area. Transesophageal echocardiogram is a readily available diagnostic tool that must be considered standard of care, not only in the operating room but also in the ICU, when dealing with this complex subpopulation of cardiac patients.Keywords
This publication has 4 references indexed in Scilit:
- Veno-venous extracorporeal membrane oxygenation with a bicaval dual-lumen catheter in a SynCardia total artificial heart patientJournal of Cardiothoracic Surgery, 2013
- The Fourth INTERMACS Annual Report: 4,000 implants and countingThe Journal of Heart and Lung Transplantation, 2012
- Parallel Application of Extracorporeal Membrane Oxygenation and the CardioWest Total Artificial Heart as a Bridge to TransplantThe Annals of Thoracic Surgery, 2009
- Patients With a Body Surface Area Less Than 1.7 m2 Have a Good Outcome With the CardioWest Total Artificial HeartThe Journal of Heart and Lung Transplantation, 2005